Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Hsu

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Oncotarget|July 9, 2014
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinomaWei-Lin Liu, Ming Gao, Kai-Yuan Tzen, et al.
Oncotarget|February 26, 2015
NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitorLan Yu, Zeng-Fu Shang, Feng-Ming Hsu, et al.
Annals of Surgical Oncology|March 14, 2014
High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapyJason Chia-Hsien Cheng, Madeline S Graber, Feng-Ming Hsu, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitorLan Yu, Vasu Tumati, Shu-Fen Tseng, et al.
Annals of Surgical Oncology|March 10, 2009
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomyFeng-Ming Hsu, Yung-Chie Lee, Jang-Ming Lee, et al.
Asia-Pacific Journal of Clinical Oncology|June 18, 2016
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancerLuhua Wang, Yi-Long Wu, Shun Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2011
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinomaFeng-Ming Hsu, Jang-Ming Lee, Pei-Ming Huang, et al.
Journal of Surgical Oncology|May 2, 2008
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized studyFeng-Ming Hsu, Chia-Chi Lin, Jang-Ming Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 16, 2021
A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapyI-Han Lee, Guann-Yiing Chen, Chun-Ru Chien, et al.
Oncology|March 12, 2024
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution ExperienceTiffany Ting-Fong Liu, Jason Chia-Hsien Cheng, Yu-Hsuan Chen, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Oncotarget|July 9, 2014
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinomaWei-Lin Liu, Ming Gao, Kai-Yuan Tzen, et al.
Oncotarget|February 26, 2015
NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitorLan Yu, Zeng-Fu Shang, Feng-Ming Hsu, et al.
Annals of Surgical Oncology|March 14, 2014
High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapyJason Chia-Hsien Cheng, Madeline S Graber, Feng-Ming Hsu, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitorLan Yu, Vasu Tumati, Shu-Fen Tseng, et al.
Annals of Surgical Oncology|March 10, 2009
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomyFeng-Ming Hsu, Yung-Chie Lee, Jang-Ming Lee, et al.
Asia-Pacific Journal of Clinical Oncology|June 18, 2016
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancerLuhua Wang, Yi-Long Wu, Shun Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2011
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinomaFeng-Ming Hsu, Jang-Ming Lee, Pei-Ming Huang, et al.
Journal of Surgical Oncology|May 2, 2008
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized studyFeng-Ming Hsu, Chia-Chi Lin, Jang-Ming Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 16, 2021
A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapyI-Han Lee, Guann-Yiing Chen, Chun-Ru Chien, et al.
Oncology|March 12, 2024
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution ExperienceTiffany Ting-Fong Liu, Jason Chia-Hsien Cheng, Yu-Hsuan Chen, et al.
Pageof 8